
Keywords: ANOVA; analysis of variance; B; buprenorphine; CCI; chronic constriction injury; CCL; CC chemokine ligands; CCR5; CC chemokine receptor 5; C1q; complement component C1q; DMSO; dimethyl sulfoxide; DRG; dorsal root ganglia; GFAP; glial fibrillary acidic pro